By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Auris Medical AG 

Falknerstrasse 4

Basel    4001  Switzerland
Phone: 41-61-201-13-50 Fax: 41-61-201-13-51



Start Up

Company News
Auris Med (EARS) Receives FDA Fast Track Designation For AM-111 In Acute Sensorineural Hearing Loss 2/24/2017 7:49:58 AM
Auris Med (EARS) And King's College London Extend Tinnitus Collaboration 2/22/2017 7:33:42 AM
Auris Med (EARS) Announces Pricing Of $10 Million Public Offering 2/15/2017 8:22:44 AM
Auris Med (EARS) Announces Proposed Public Offering Of Common Shares And Warrants 2/15/2017 7:47:23 AM
Auris Med (EARS) Expands Clinical Development Pipeline With Intranasal Betahistine For The Treatment Of Meniere's Disease And Vestibular Vertigo 2/6/2017 9:20:32 AM
Auris Med (EARS) Expands Beyond Cochlear Therapies To Include Vestibular Therapy: Intranasal Betahistine, AM-125 2/3/2017 11:37:31 AM
Auris Med (EARS) On Track To Resume Enrollment Of Keyzilen Tinnitus Program Following Regulatory Feedback 12/6/2016 9:25:06 AM
Auris Med (EARS) Provides Business Update And Reports Third Quarter 2016 Financial Results 11/10/2016 9:02:26 AM
Auris Med (EARS) To Announce Third Quarter 2016 Financial Results And Host Conference Call On Thursday, November 10, 2016 11/4/2016 10:08:57 AM
Auris Med (EARS) Announces AAO-HNSF Annual Meeting Activities 9/13/2016 10:53:44 AM